ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.

Ignace Vergote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.